An approach to developing a prediction model of fertility intent among HIV-positive women and men in Cape Town, South Africa: a case study by Bai, Dan et al.
Bai, D. et al. (2016). An approach to developing a prediction model of fertility intent among 
HIV-positive women and men in Cape Town, South Africa: a case study. 
AIDS and Behavior, 21: 597 – 609. 
http://dx.doi.org/10.1007/s10461-016-1441-7  
 
 
University of the Western Cape Research Repository                                                                     jem57@cumc.columbia.edu      
 
An approach to developing a prediction model of fertility intent 
among HIV-positive women and men in Cape Town, South Africa: a 
case study 
 
Dan Bai, Cheng-Shiun Leu, Joanne E. Mantell, Theresa M. Exner, Diane Cooper, Susie 
Hoffman, Elizabeth A. Kelvin, Landon Myer, Debbie Constant and Jennifer Moodley 
 
Abstract   
As a ‘case-study’ to demonstrate an approach to establishing a fertility-intent prediction 
model, we used data collected from recently diagnosed HIV-positive women (N = 69) and 
men (N = 55) who reported inconsistent condom use and were enrolled in a sexual and 
reproductive health intervention in public sector HIV care clinics in Cape Town, South 
Africa. Three theoretically-driven prediction models showed reasonable sensitivity (0.70–
1.00), specificity (0.66–0.94), and area under the receiver operating characteristic curve 
(0.79–0.89) for predicting fertility intent at the 6-month visit. A k-fold cross-validation 
approach was employed to reduce bias due to over-fitting of data in estimating sensitivity, 
specificity, and area under the curve. We discuss how the methods presented might be 
used in future studies to develop a clinical screening tool to identify HIV-positive 
individuals likely to have future fertility intent and who could therefore benefit  from  sexual  
and  reproductive  health  counselling around fertility options. 
 
Introduction 
With  increased  availability  and  access  to  antiretroviral (ARV) drugs, many HIV-positive 
women and men have begun to feel more assured that they can lead healthy and 
productive lives, including realizing their desires to have children. While it often has been 
assumed that HIV-positive individuals do not want children, accumulating evidence 
indicates that some HIV-positive individuals throughout the HIV care trajectory—from 
recent diagnosis to achievement of viral suppression as a result of ARVs— wish to have 
children [1–10]. South Africa has been the site of numerous studies of fertility intentions 
among HIV-positive persons. For example, in Cape Town, about 50 % of HIV-positive 
women and men who entered the HIV care system were found to be seeking or were open to 
the possibility of having children [11]. Eleven percent of women attending HIV Care 
services in Cape Town had been pregnant since becoming aware of their diagnosis, and 
nearly all pregnancies were unintended [8]. 
 
Many studies have identified correlates of fertility intent among HIV-positive persons [5–
19], with the majority examining the cross-sectional association between variables of 
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interest and participants’ fertility intent. However, use of prior information to predict 
future fertility intent, often referred to as a ‘‘prediction model’’, has rarely been undertaken. 
Prediction models serve an additional purpose beyond that of testing associations between 
single variables and the outcome. In an association study, the main focus is to examine the 
relationship between the outcome and independent variables. While the primary goal is to 
predict a diagnostic or prognostic outcome, the strength of the association may not 
provide sufficient information for prediction. For example, in our prior analysis of baseline 
data from a study of fertility intentions among HIV-positive women and men, we found a 
significant association between gender and fertility intent (OR 5.64, p \ 0.001), as well 
as educational level and fertility intent (OR 0.79, p \ 0.001) [18]. Such findings indicated 
that men are 5.64 times as likely as women to have fertility intent, and participants with 
less than a high school education are 3.22 times as likely as those who graduated from high 
school to have fertility intent. However, an odds ratio or any other statistic measuring the 
strength of association (such as risk ratio and risk difference) does not reveal the probability 
of fertility intent for a particular individual. That is to say that knowing a patient’s gender 
and educational level as well as their strength of association with the outcome is not enough 
for a clinician to determine the likelihood of patients’ future fertility intentions. To answer 
a question such as ‘‘Does a person with certain characteristics (e.g., highly educated 
women) have a high likelihood of fertility intent?’’ a prediction model for fertility intent is 
needed. A prediction model with good ability to discriminate allows one to properly predict 
a binary outcome that may be difficult or costly to obtain at the current time, such as cancer 
or neurological disease, using information that is relatively easy to collect or available prior 
to the development of the outcome [19–23]. 
 
Prediction models have been widely used in studies evaluating responses to clinical 
interventions, combining a number of characteristics to predict a diagnostic or prognostic 
outcome [22]. This modeling approach guides the selection and interpretation of 
subsequent diagnostic tests, and provides estimates of the clinical probability of having 
certain diseases [23–25]. Thus, identification of potential clinical markers can help 
clinicians predict which patients are at high risk for a particular disease. In behavioral 
studies, a prediction model could be used to predict participants’ future behavior or 
intentions based on certain characteristics included in the model. Such models have been 
established and applied to predict depression [26] and suicidal intent [27] in various 
populations. In this paper, a case-study is used to illustrate an approach to developing 
prediction models rather than trying to establish a ‘‘definitive’’ prediction model of fertility 
intent. The models are employed to illustrate how such information could help clinicians 
and counselors address reproductive health issues more effectively with their HIV-positive 
patients—by identifying those who might benefit from discussion of pregnancy desires, 
regardless of where they fall on the HIV care continuum. We further illustrate the added 
value  of a  prediction  model for clinical  and social scientists above what we can learn from 
testing associations between predictor variables and outcomes, by developing and 
evaluating several prediction models for fertility intent among a sample of HIV-positive 
women and men in Cape Town, South Africa. Such a statistical approach  provides  a  
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useful  tool  for  future  researchers seeking to model determinants not only of fertility 
intent but of other behaviors that have public health significance. 
 
Methods 
Study Population, Recruitment and Intervention 
We used available data from Emtonjeni (spring of knowledge), a recently completed Phase 
II randomized futility trial focused on promoting reproductive choices and sexual health 
among women and men living with HIV. This study was designed to evaluate a multi-level 
intervention to integrate sexual and reproductive health into care for newly-diagnosed 
HIV-positive persons who were ineligible for antiretroviral therapy (ART) due to CD4? 
counts C200 mm. Although this pre-ART group was monitored every 6 months for ARV 
eligibility, they were not viewed as high a priority for services relative to individuals seen in 
HIV testing, PMCT? and ART settings. Our focus on HIV-positive persons at their entry 
point into the HIV care system allowed for ‘‘early’’ intervention, as significant numbers of 
women become pregnant prior to becoming eligible for ART [8, 28]. At the time of study 
implementation, between August 2010 and August 2011, neither general medical nor HIV-
specific treatment practices routinely addressed concurrent HIV/STI and sexual and 
reproductive health needs of people living with HIV. 
 
Four typical public sector HIV care clinics in Cape Town, South Africa, serving low-income 
individuals from the surrounding townships were pair matched, and the two clinics within 
each pair were randomized to either a three-session counselor-delivered enhanced 
intervention or a standard-of-care counselor-delivered intervention. Through values-neutral 
counseling, the enhanced intervention aimed to help individuals explore the pros and cons of 
conception versus pregnancy prevention, and approaches to STI prevention within their 
unique life circumstances, with the goal of facilitating personal decision-making to 
optimize their own health and that of existing and future child(ren). In addition to 
counseling of HIV-positive individuals, the enhanced intervention included on-site 
contraceptive services and a brief ‘‘milieu intervention’’ for staff. The major outcome was 
adherence to safer sex guidelines (no condom-unprotected sex) among those wishing to 
avoid pregnancy, or adherence to safer conception guidelines among those seeking 
conception. Data from this study allowed us to delineate the proportion of HIV-positive 
women and men who did and did not opt to seek pregnancy, and whether pregnancies 
were pursued in line with best practices recommendations. 
 
Prior to receiving their CD4cell count results, a clinic nurse gave clients in the waiting area 
an Information Sheet describing the study (as one about sexual and reproductive health 
services for HIV-positive women and men aimed at increasing understanding about how to 
improve the quality of these services within the HIV care system). Those who were 
interested were referred to study staff for more information. Potential participants were not 
informed of the study eligibility criteria. 
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Eligible participants had to be  C18 years,  attending the clinic to receive their first CD4? 
cell count results since testing HIV-positive and therefore not on ARVs, not pregnant, 
report unprotected sex in prior 3 months and/or intent to conceive within the next 6 
months, and be willing and able to provide informed consent. These criteria were 
selected because our intervention focused on both avoidance of pregnancy and 
adherence to safer conception among HIV-positive individuals who were intending to 
conceive. The sample for this analysis was limited to 197 participants who reported 
inconsistent condom use in the past 3 months, some with and without immediate fertility 
intent at baseline. There were 151 valid records on their fertility intent at FU2,  and  127 
valid records on baseline CD4? count. We excluded 73 participants due to incomplete 
information on predictor or outcome variables. Thus, analyses in this paper are based 
on 124 complete cases (for all predictors and outcomes). 
 
Ethical Considerations 
Informed consent (including for access to medical records) was obtained from all interested 
eligible participants. Ethical approval was obtained from the New York State Psychiatric 
Institute-Columbia University Department of Psychiatry and the Human Research Ethics 
Committee of the University of Cape Town. 
 
Data Collection 
Face-to-face interviews were conducted in isiXhosa or English, according to client 
preference, by experienced gender-matched interviewers in privacy in the clinic. The 
baseline interview was administered prior to participants’ receipt of CD4? cell count 
results, except for eight participants, who completed this interview within 1 month of 
receiving their results. Participants were again interviewed 3 months (FU1)  and 6 months 
(FU2) after baseline, although only baseline and FU2 data were included in this analysis. 
Participants received 50 rand ($7.00 US at the time of the study) for completing the 
baseline interview, and 100 rand ($14.00 US at the time of the study) for the 6-month 
follow-up interview. 
 
Measures 
The  outcome  of  interest  was  the  participant’s  future intention for conception 
measured at the FU2 interview. This binary outcome was created based on the participant’s 
response to the question, ‘‘Are you thinking about trying to have a child in the next 12 
months?’’ Independent variables considered in the prediction models included baseline 
measures of (1) demographic characteristics (gender, age, educational level, work status 
[working full-time or part-time, self-employed, unemployed], place of residence [living in 
an informal dwelling/rents a room in someone else’s home, or owns/rents home], and 
number of children currently under participant’s care); (2) health status (years since HIV 
diagnosis and CD4? cell count [from the medical record]); (3) sexual partners and practices 
(whether the participant had  a  main  partner  currently  or  in  past 3 months, and if so, 
whether s/he lived with that partner); (4) disclosure of HIV status to main partner; (5) 
reproductive history over past 3 months (contraceptive practices, number of biological 
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children, relying on a hormonal method in relationship with current/recent main partner, 
and participant’s perception of main partner’s fertility intent [interested in immediately 
conceiving a child, no immediate intent, uncertain about partner’s intent, or partner 
uninterested in conceiving a child]); and (6) intervention condition (three-session provider-
delivered enhanced sexual and reproductive health intervention versus standard of care). 
We asked about fertility intent only of participants, not specifically with which partner. 
‘‘Main’’ partner variables were used as covariates since presumably women and men would 
know more about main and less about their casual partners; slightly more than two-thirds 
(68.4 %) of participants had only a main partner. Although participants were asked about 
the HIV status of their partners, many did not know their partners’ status; therefore, we 
excluded this variable from the analysis. 
 
The participant’s fertility intent at baseline also was considered as a potential predictor of 
FU2 fertility intent. In addition, we assessed self-efficacy for communicating with one’s 
partner about safer sex and sexual and reproductive health, a measure comprising 9 items 
with responses in a 4-point Likert format (sample item: ‘How confident are you that you 
could convince [a/your] regular partner in the next 3 months to use condoms?’, response 
options ranging from ‘very unconfident = 1’ to ‘very confident = 4’; Cronbach’s alpha = 
0.61), and self-efficacy for obtaining information on SRH services, consisting of 4 items and 
using the same format (sample item: ‘How confident are you that you could find additional 
information about contraceptive options at a clinic or hospital?’; Cronbach’s alpha = 
0.63). 
 
Procedures to Establish a Prediction Model 
To establish a prediction model for fertility intent, we first used the data collected from our 
sample to identify a list of potential predictors for this outcome. A variable was considered a 
potential predictor if it had theoretical relevance, clinical importance (e.g., gender and 
intervention condition), or showed significance in a simple logistic regression [14] to predict 
our outcome. We then used these variables to  fit  a  multiple  logistic  regression  model  of  
the  form 
 
 
predicted probability of fertility intent at FU2, p^ , was then calculated using the formula 
where p is the probability of fertility intent (yes vs. no) at 6 months follow-up (FU2) given 
male gender (X1), years of education (X2), participant had fertility intent at baseline(X3), 
number of biological children (X4), pill/injectable contraceptive use (X5), and other 
potential predictors (X6 to Xm). After obtaining the estimated regression coefficients ^b0; 
^b1; ^b2; ^b3; ^b4; . . .; ^bm, the predicted probability of fertility intent at FU2, ^p, was 
then calculated using the formula 
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Once p^  for each participant was calculated, we then aimed to choose an optimal cut-off 
point (of p^ ) to distinguish between participants with and without fertility intent at FU2. 
The criteria used to select an optimal cut-off point are thoroughly discussed in the literature. 
There are simple criteria that involve only sensitivity and specificity such as (1) setting a 
minimum value for specificity and maximizing sensitivity, or setting a minimum value for 
sensitivity and maximizing specificity [29–31]; (2) maximizing the product of specificity 
and sensitivity [32]; (3) maximizing the sum of specificity and sensitivity (i.e., maximizing 
Youden’s Index) [33]; and (4) maximizing the diagnostic odds ratio [34–36]. More complex 
criteria further take costs of misclassifications into consideration such as (1) the 
Generalized Youden Index [35, 37, 38]; (2) cost-benefit methodology [39–41]; and (3) 
the misclassification cost term [42–44]. Criteria based on maximization of the Kappa Index 
[35, 45] make full use of the information in the confusion matrix (a  2X2  table  that  
reports  the  number of false positives, false negatives, true positives, and true negatives) to 
assess the improvement over chance prediction. 
 
Costs of misclassifications can also be included in criteria such as the Weighted Kappa 
Index [34, 46]. Alternatively, researchers/clinicians can base their selection of optimal  
cut-points on positive  predictive value (PPV) and negative  predictive  value  (NPV).  
Vermont et al. [31] discussed criteria (1) to set a minimum value for PPV or NPV or (2) to 
maximize the sum or product of PPV and NPV. Likelihood-based methods such as setting a 
particular value for the negative or positive diagnostic likelihood ratio [47, 48], and test-
based approaches such as minimizing the p value associated with the statistical Chi 
squared test which measures the association between the marker and the binary result 
obtained on using the cut-point [49–52] have also been discussed. In cases where 
prevalence is the parameter of primary important, one can use criteria based on setting (1) 
the closest value to observed prevalence [53] or (2) sample prevalence to predicted 
prevalence [53, 54]. Given that many more criteria in addition to the above mentioned 
ones are available to select the optimal cut-point, researchers/clinicians should choose 
the one that best fits their practical needs. Most importantly, whatever method is going to 
be used to select a cut-point, it should be specified a priori to preclude researchers 
from changing the selection criteria after having seen the data, to avoid diminishing the 
scientific rigor and replicability of the study. For simplicity of discussion, we chose to 
maximize the Youden index, which  is  equal  to  the  sensitivity ? specificity -1 [33], as 
our criterion for selecting the optimal cut-point. Once that optimal cut-point was 
identified, the predicted fertility intent status at FU2 for each of our study participants was 
determined by the following algorithm: if p^  was greater than the selected cut-point, that 
participant was classified by the model as having immediate fertility intent at 6-month 
follow-up; alternatively, if p^  was at or below the optimal cut-point, the participant was 
classified by the model as having no immediate fertility intent at 6 months follow-up. 
 
Evaluation of Prediction Model 
To determine the accuracy of a prediction model, we evaluated the model’s discrimination 
ability, i.e., the ‘‘ability of the model to distinguish correctly the two classes of outcomes’’ 
http://repository.uwc.ac.za
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[55]. Sensitivity, specificity, and the area under a receiver operating characteristics (ROC) 
curve (AUC) are often used to evaluate a model’s predictive capacity (probability of 
correct classification), and thus model fit. In Table 1, we define ‘condition’ as the 
outcome, fertility intent at 6-month follow-up, for the prediction model, as determined by 
a ‘‘gold standard’’ as used in medical diagnostics to refer to ‘‘disease diagnosis’’ using the 
most appropriate and widely accepted methods. Results based on  a gold standard are 
usually treated as a substitute for the true ‘disease’ status to test a diagnostic method, or, as 
in this paper, a prediction model. In our study, the gold standard was the actual 
reported fertility intent at FU2, and the expected fertility intent from the prediction 
model was compared to it to evaluate the accuracy of the prediction model. Subjects in 
area A are true positives (tested positive and condition positive), subjects in area B 
are false positives (tested positive but condition negative), subjects in area C are false 
negatives (tested negative but condition positive), and subjects in area D are true 
negatives (tested negative and condition negative). Sensitivity refers to the proportion of 
true positives among total condition positives (A/ (A ? C) in the table), i.e., probability 
of testing positive, given that the subject is condition positive (having certain disease or 
intent), whereas specificity refers to the proportion of true negatives among total 
condition negatives (D/(B ? D) in the table), i.e., probability of testing negative, given 
that the subject is condition negative. An ROC curve, on the other hand, provides 
detailed visual information about the performance of a prediction model. In an ROC 
curve, plotting the sensitivity against 1-specificity for various cut-points from 0 to 1 
can help researchers to select a better prediction model and corresponding optimal 
cut-point. Specifically, the intercept of the ROC curve with the line at 90 degrees to the 
no-discrimination line is equivalent to the Youden index (i.e., sensitivity ? 
specificity -1), so the larger the intercept the better the performance of the 
prediction model. Furthermore, if one chooses the Youden index as the selection 
criterion for identifying the optimal cut-point, the corresponding cut-point of the 
largest intercept in the ROC curve will be the optimal cut-point. Another useful 
statistic generated by the ROC curve is the area under the curve. It represents the 
probability that a randomly chosen condition positive (diseased, or in this case, having 
fertility intent) subject is (correctly) rated or ranked with greater suspicion 
(probability tested positive) than a randomly chosen condition negative (non-diseased, or 
in this case, no fertility intent) subject [19]. Thus, the prediction model with the 
greater AUC will have better ability to discriminate patients with and without the 
disease. The classification of sensitivity, specificity, and AUC vary with the nature of 
the ‘disease’. For those statistics,  one  generally  considers  a  value  of  0.90  or above as 
excellent and 0.80 or greater as good. 
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Correction for Potential Bias in Estimating Sensitivity, Specificity and AUC 
As the cut-point for the predicted probability is based on selecting an optimal 
combination of sensitivity and specificity from the  data used  to build  the model,  the 
direct estimate of these two statistics using data from the entire sample is upwardly 
biased [33, 56]. Therefore, if we take another independent sample from the same 
population, fit the same model, and use the same cut-point to estimate the sensitivity and 
specificity, the result may not be as good as that obtained from the current data. This is 
called overfitting. To reduce the potential for bias due to overfitting, we used a k-fold 
cross-validation procedure to estimate the sensitivity, specificity, and AUC for the derived 
prediction model [55, 57]. In k-fold cross-validation, the original sample is randomly 
partitioned into k equal (or nearly equal) sized subsamples. Of the k sub-samples, a 
single subsample is retained as the validation set for testing the model, and the 
remaining k - 1 sub-samples are used as the training set. The cross-validation process is 
then repeated k times, with each of the k sub-samples used exactly once as the validation 
set. For each cross-validation process, we used one training set to fit a logistic regression 
model (as shown above), obtained the estimated regression coefficients, calculated the 
predicted probability of fertility intent at FU2 (i.e., p^ ), and selected an optimal cut-point 
to distinguish participants with fertility intent from those without fertility intent according 
to the algorithm described above. We then applied the same regression coefficients 
obtained from that training set to calculate p^  for each participant in the corresponding 
validation set, used the selected optimal cut-point (chosen from the training set) to 
classify the participant’s fertility intent, and obtained one estimate of the sensitivity, 
specificity, and AUC. The entire process was repeated k times and the final estimate of 
sensitivity, specificity and the AUC was the average of the k estimates. 
 
For the k-fold cross-validation procedure, there are no definitive guidelines or  rules for  
choosing the  number k. Generally speaking, k = 5 and 10 are the most common 
selections of k for cross-validation. However, as the sample we used for illustration in this 
paper for the prediction model was relatively small (N = 124) and had low prevalence (of 
outcome) (only 20 cases of fertility intent at FU2), we chose a 3-fold and 5-fold cross-
validation method to  avoid potential issues caused by the small sample size for the 
validation set. With such choice of cross-validation procedure, we were able to allow  for  
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a  reasonable  number  of  records  in  each validation set (41 or 42 records (6 or 7 
positives) for 3-fold method and 24 or 25 records (4 positives) for 5-fold method). 
However, as the number of positives in each set was still relatively small (when k = 5, 
there are only 4 cases in each validation set), the validated sensitivity will be sensitive 
to the selection of random partition. Therefore, we iterated the cross-validation 
procedure (100, 1000, and 5000 times) to study the stability of our estimated statistics. 
Data were managed using the PASW SPSS version 18.0 [58] (SPSS Inc., Chicago, IL); and 
all analyses were conducted using SAS software version 9.3 [59]. 
 
Results 
Background  Characteristics 
Participants were, on average, 30.7 years of age and had completed about 10 years of 
school. There was a greater proportion of women (55.6 %) than men (44.4 %). More than 
half of participants worked full- or part-time, and 63.7 %  resided  in  an  informal  
dwelling  or  lived  with someone else. On average, they had two biological children and 
cared for three children. Three-quarters were diagnosed with HIV within the previous 
year, and the median CD4? cell count was 408 cells/mm3 (values ranged  from  73  to  
1260,  IQR = 216);  32.3 %   had CD4 \ 350). All participants reported having a 
main partner, and 48.4 % lived with their main partner. Nearly two-thirds (64.1 %) 
indicated that their main partner knew they were HIV-positive. About two-fifths (43.6 
%) of participants reported that they or their partner used hormonal contraception. 
 
Establishing Prediction Models 
To illustrate a procedure for establishing prediction models, we used the information 
obtained from 124 study participants to build three models to predict fertility intent. Model 
1 included all potential predictors listed above in the Measures Section (Table 2). Model 2 
contained all of the predictors in Model 1, with the exception of age, education, and 
diagnosis within 1 year, due to the weak association these variables had with the outcome 
in Model 1 (Table 3). Model 3 was the model identified by a stepwise selection procedure in 
which all variables considered in Model 2 were entered. It required a significance level of 
0.10 for variable entry and 0.05 for variable retention in the model. These inclusion and 
exclusion criteria are commonly used for larger sample studies, but again, since our analysis 
was for illustrative purposes, we employed the same significance  levels  for  the  selection  
criteria.  Based  on  these criteria, only three predictors were selected for entry in Model 
3: hormonal contraception use (pill/injectable), participant’s fertility intent at baseline, and 
log transformed CD4? cell count (Table 4). ROC curves for the three models (using the data 
from the entire sample of 124 participants) are shown in Fig. 1. 
 
k-Fold Cross-Validation 
For each of the three models, we report the average sensitivity, specificity, and AUC 
obtained from 100, 1000, and 5000 iterations of k-fold (k = 3, 5) cross-validations, 
respectively (Table 5). As shown in Table 5, the sum of sensitivity and specificity, as well 
as AUC estimated through the cross-validation procedure, were uniformly smaller than 
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those obtained via a procedure without cross-validation for all three models. Such findings 
demonstrated the existence of over-fitting. For example, for Model 3, the sensitivity, 
specificity, and AUC are 0.800, 0.750, and 0.788, respectively, without cross-validation; 
however, those values drop to 0.640, 0.750, and 0.758, respectively, for 3-fold cross-
validation (with 5000 iterations). 
 
To illustrate the potential clinical utility of a prediction model, we provide a ‘‘diagnosis’’ 
chart that is easy for a clinician  to  use,  based  on  Model  3  (Table 6).  For  any patient, 
based on responses to the two dichotomized questions in the prediction model and the cut-
point of CD4? count for each category, a clinician could easily predict the patient’s fertility 
intent 6 months after their initial baseline assessment. For example, if an HIV-positive 
patient with a CD4? count over 643 reports current fertility intent and hormonal 
contraceptive (pill/injectable) use (Row 1, Table 6), it indicates her high probability of 
having fertility intent in the future according to our prediction model. In such a case, the 
counselor would consider initiating a discussion about safer conception strategies to 
prevent possible HIV transmission due to unsafe sex. Or, if a patient at baseline indicated 
hormonal contraceptive use, and no fertility intent (Row 2, Table 6), and had a CD4? 
count greater than about 935, the model suggests that there may be a change in fertility 
intent at 6-month follow-up visit—and that it is worth a provider’s time to initiate a 
discussion with a patient who, based on their initial contraceptive use and intentions, 
would not necessarily have been ‘flagged’ as someone with whom to explore reproductive 
issues again. Thus, without a prediction model, this could be difficult for a clinician to 
predict. Although the diagnosis chart we built from Model 3 is easy to interpret and use in 
practice,  we  need to keep  in mind that the accuracy of the prediction is imperfect. 
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Discussion 
Addressing the reproductive health needs of HIV-positive women and men remains a 
challenge. The primary purpose of this paper is to highlight the need for developing and 
testing prediction  models  to estimate the  probability of future fertility intent among HIV-
positive individuals, and to provide a methodological approach for establishing a 
prediction model and evaluating its ability to correctly discriminate. We used available 
baseline data from a recently completed intervention study that promoted the integration 
of sexual and reproductive health into HIV care services to demonstrate an approach. This 
study was not designed to develop a screening or prediction model for fertility intent for 
application in clinical settings. Instead, the final selected model in our case study was for 
illustrative purposes only. The models we fitted were not intended to have clinical 
meaning nor lead to change in practice. Therefore, some important predictors were not 
measured and the sample size was insufficient for drawing definitive conclusions. 
 
There are statistical and clinical considerations for model selection. Statistically speaking, 
the model with higher accuracy of discrimination and greater generalizability is more 
preferable. Therefore, we would choose Model 3 over Models 1 or 2 due to its higher 
sensitivity, specificity, and AUC after cross-validation. Note that, as we previously pointed 
out, the criterion for model selection should not rely on the crude estimate of sensitivity, 
specificity, and AUC because they are upwardly biased. While Model 1 looks superior 
from the crude estimates (due to a greater overfitting), Model 3 is still more favorable 
because its cross-validated statistics are better. Clinically,  a  prediction  model  with  few  
variables  is  more appealing, as the information is easier to obtain. Therefore, from  a  
clinical  stand  point,  Model  3  is  still  the  most preferable model among the three 
candidates. 
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When evaluating a prediction model, we often face the question of which is more 
important—sensitivity or specificity? It depends. For some severely adverse outcomes, 
for example, suicide intent, we definitely would want the sensitivity to be as high as 
possible (with a clinically acceptable corresponding specificity) to preclude missing any 
persons with suicide intent and to initiate preventative actions. For diseases whose 
treatment might be painful or time-consuming to the patient, we would want the 
specificity to be high (with a clinically acceptable corresponding sensitivity) to avoid 
imposing a burden on true negatives. The Youden index is one of the most common ways 
to choose a cut-point for a prediction model, but there may be situations in which two or 
more cut-points have optimal and very close Youden indices; for example, if two cut-points 
A and B have very close Youden indices of 1.61 versus 1.60, A with sensitivity 0.75 and 
specificity 0.86, B with sensitivity 0.85 and specificity 0.75. A researcher will then have to 
select the final cut-point based on A and B; if sensitivity is more important, one may want to 
choose B even if its Youden index is not optimal. In our case example of identifying HIV-
positive persons interested in conception, the cost-benefit issues to be weighed involve 
risks to uninfected partners and infection of the child, benefits for averting new 
infections, balanced with providers’ time to address other medical concerns/issues. In such 
a case we would argue for higher  and  more stable sensitivity so that we can offer related 
information and support to people with positive fertility intent. Since these are HIV-
positive individuals, a clinician would want to identify those who are likely to want to 
conceive so that he/she can give them information about how to do so while minimizing the 
risk of HIV transmission to an uninfected partner. From the results, Model 1 is the least 
stable, and Model 2 has lower sensitivity and less stability than Model 3. Therefore, Model 3 
would be the best choice; also, it has few predictors (only three) and information on the 
predictors is easy to obtain. 
 
Our case study, designed to illustrate the establishment of a clinical prediction model to 
estimate the probability of future fertility intent, has a number of limitations. We developed 
and tested the model on a small sample with unique characteristics and with a relatively 
limited number of predictor variables. Even though we found that Model 3 was superior to 
the other two models we tested, this model is not yet primed for clinical application. A 
considerably larger and more representative sample of our HIV-positive target population 
and a greater array of predictor variables (e.g., motivation for childbearing, gender norms, 
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social support) are needed to establish a fertility intent prediction model for application in 
clinical practice. However, our study begins to provide data on an approach to developing a 
clinical practice model based on a larger and more representative sample. Given that 
fertility desires and ability to report these are likely to be highly context-specific and vary 
between clinic populations (e.g., hospital vs. primary care) and  communities (e.g., settings 
with heavy social expectations for childbearing vs. more limited expectations in others), a 
single generalizable prediction model for all populations is neither realistic nor ideal. 
Rather, the approach used in our case study could be applied in different settings to assist 
in deriving local predictors. 
 
Our sample was limited to HIV-positive women and men who were inconsistent condom 
users and linked to HIV care and therefore is not representative of all HIV-positive 
individuals in Cape Town. Also, our case example has a limited follow-up period—fertility 
intentions are likely to  evolve  over  a  much  longer  time  period  than 6 months, and to be 
dynamic with changing health as well as with life and partnership circumstances. 
Therefore, anyone seeking to build a practical prediction model for fertility intentions in 
clinical care needs to recognize that fertility intent is a moving target. Additional studies 
are needed to identify variables significantly associated with fertility intent for building an 
initial prediction model. A well-defined k-fold cross-validation procedure could help to 
reduce potential bias of over-fitting and to assess the predictive accuracy of the model in 
the target population. Moreover, a much larger sample of HIV-positive individuals will be 
needed to give greater confidence in the precision and predictive power of a prediction 
model of fertility intent that has clinical relevance. Note that once a prediction model is 
established, it is necessary to evaluate its performance in datasets that were not used to 
develop the model before its use in clinical practice [60]. This is often referred to as 
external validation. External validation is essential as it quantifies optimism from model 
overfitting or deficiencies during the development of a prediction model and evaluates the 
validity of the model in different locations with a similar population [61]. We did not 
conduct external validation for any of three models discussed in this paper because they 
were used only for illustration. 
 
Fertility planning should be an integral part of comprehensive care for HIV-positive 
women and men, introduced once an HIV-positive individual is engaged in HIV care. 
Numerous studies have shown that health care providers often refrain from asking HIV-
positive individuals, especially men, about their fertility desires [62]. Among many 
clinicians there is low awareness of safer conception options and that HIV serodiscordance 
can be maintained in a couple [62]. There is also a perception that in the pre-ART period 
couples do not consider fertility issues [62], despite the fact that fertility planning is 
critical in this group. Use of a brief screening tool consisting of variables identified in a 
prediction model can serve to jumpstart health care providers’ discussion of fertility 
intent with HIV-positive individuals, prepare providers to develop a plan with their 
patients, and guide patients to make informed decisions about both contraception and 
safer conception options in a non-judgmental manner [63]. Both The Southern African 
Clinicians Society [64] and the South African National Contraception and Fertility 
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Planning Policy and Service Delivery Guidelines [65] call for a stronger move toward 
routine assessment of fertility options for people living with HIV (PLHIV). In both 
resource-rich and resource-limited settings where time constraints increasingly challenge 
the amount of time health care providers spend  with patients, an evidence-based 
screening tool derived from a prediction model could be utilitarian, helping providers to use 
their time more effectively while accelerating early interventions for PLHIV. 
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